PAGP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Plains GP Holdings LP (PAGP) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock shows a constructive technical setup and sentiment is moderately supportive, but there is no Intellectia buy signal, no recent news catalyst, and the analyst picture is mixed rather than decisively bullish. My direct view: hold and wait for either a clearer fundamental catalyst or a better entry, rather than committing fresh capital immediately.
PAGP is in a short-term bullish trend. MACD histogram is positive and expanding, and the moving averages are aligned bullishly (SMA_5 > SMA_20 > SMA_200), which supports upward momentum. RSI_6 at 66.87 is elevated but not yet extreme. Price closed at 24.43, just above pivot 23.707 and near first resistance at 24.355, with the next resistance at 24.755. This suggests the stock is trending up, but it is close to near-term resistance and not at an obvious discount. The pattern-based forecast also leans positive, implying upside over the next week to month.
["Goldman Sachs upgraded PAGP to Neutral from Sell and raised the target to $24, citing a stronger crude price environment and improving growth outlook.", "Goldman also sees Plains as a takeover candidate, which can support sentiment.", "Morgan Stanley and Citi both raised price targets recently, signaling improving Street expectations.", "The company benefits from structurally higher crude prices and increased U.S. producer activity.", "Bullish technical trend and supportive options positioning reinforce momentum."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "Barclays still rates the stock Underweight, showing the Street is not uniformly bullish.", "Hedge funds and insiders are neutral, with no notable buying trend.", "The stock is trading close to resistance, limiting immediate upside from current levels."]
No usable financial snapshot was provided due to an error, so the latest quarter financials cannot be assessed directly. Because of that, there is no confirmed quarter-by-quarter growth readout available here. Based on analyst commentary, however, estimates appear to have improved recently, with higher crude prices and better cash flow expectations supporting the outlook.
Analyst sentiment has improved over the past two months. Goldman Sachs upgraded the stock to Neutral from Sell and lifted its target to $24. Morgan Stanley raised its target to $26 and kept Equal Weight, Citi lifted its target to $23 and kept Neutral, and Barclays remains cautious with an Underweight rating and a $21 target. Overall, the Wall Street view is mixed: the pros see better crude-driven growth, stronger cash flow, and potential M&A appeal, while the cons still include limited conviction and at least one bearish house. Net takeaway: sentiment has shifted upward, but it is not a consensus buy.
